v3.26.1
Unaudited Condensed Consolidated Interim Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (22,986) $ (13,696)
Adjustments required to reconcile net loss for the period to net cash used in operating activities:    
Depreciation 5 528
Stock-based compensation 2,059 1,355
Finance income, net 382 247
Revaluation of contingent consideration 3
Loss (income) from change in fair value of liability-classified warrants 12,458 (2,412)
Day one loss upon entering transaction 5,226
Private Placement Warrants issuance cost 186
Gain from deconsolidation of subsidiary (1,860)
Changes in balance of severance pay fund 1
Changes in operating assets and liabilities:    
Loss from sale and disposal of fixed assets, net 165
Decrease (increase) in trade receivables 511
Other current assets (1,419) 1,096
Trade accounts payable 422 294
Other accounts payable and current portion of lease liabilities (1,572) (2,404)
Net change in operating leases 3 3
Net cash used in operating activities (6,584) (14,821)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in short term securities - net (176)
Cash used in purchase of subsidiaries, net (378)
Decrease in cash as a result of deconsolidation of subsidiary (996)
Purchase of fixed assets (2)
Proceeds from sale of property and equipment 0 109
Net cash provided by (used in) investing activities (1,552) 109
CASH FLOWS FROM FINANCING ACTIVITIES:    
Issuance of Common Stock under February 2025 SPA 996
February 2025 SPA issuance costs (118)
Issuance of Common Warrants under February 2025 SPA 4,531
Issuance of Common Stock under Inducement Letter Agreements 6,473
Proceeds from related party loan 656
Proceeds from issuance of preferred share and warrants under January 2026 private placement, net of issuance costs 2,622
Short-term bank credit 7
Pre-Funded Warrants and Common Warrants exercise 2
Issuance of Common Stock under At the Market Sales Agreement, net of $39 issuance costs 291
Repayment of long-term loans (48)
Net cash provided by financing activities 3,528 11,884
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (4,608) (2,828)
Effect of exchange rate changes on cash and cash equivalents 39
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 4,955 17,975
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 347 15,186
RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS    
Cash and cash equivalents 347 14,046
Restricted cash 1,140
Total cash and cash equivalents and restricted cash 347 15,186
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest 5 10
Taxes paid 3
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Property and equipment purchases included in other accounts payable and trade accounts payable 2
Accrued Preferred dividends on Series Y Convertible Preferred Stock 85
Exercise of warrants into common stock 16,785
Conversion of Series Y Convertible Preferred Stock into common stock 85
Reclassification of embedded conversion derivative upon conversion of Series Y Convertible Preferred Stock $ 7,818